E(z) Activators are a diverse group of chemical compounds that serve to enhance the histone methyltransferase function of E(z), which is a critical component of the Polycomb Repressive Complex 2 (PRC2) responsible for tri-methylating lysine 27 on histone H3, a key epigenetic mark for gene silencing. S-Adenosylmethionine is a direct activator, supplying the methyl groups that E(z) transfers to histones, while SAH Hydrolase Inhibitor and 3-Deazaneplanocin A elevate the levels of this methyl donor within cells, thus increasing E(z)'s activity. Methylstat, by inhibiting the removal of methyl groups from histones, effectively increases the permanence of E(z)-mediated methylation. Similarly, DZNep, by depleting trimethylated H3K27, heightens the functional demand for E(z) activity to maintain repressive chromatin states. BIX-01294 and Chaetocin, by inhibiting other histone methyltransferases like G9a and SUV39H1, can cause a compensatory increase in E(z) activity to restore epigenetic balance.
Further enhancing the influence of E(z), Parthenolide and Disulfiram modulate transcriptional and metabolic pathways that can impact E(z) function. Parthenolide alters transcriptional networks that can upregulate genes involved in the PRC2 complex, while Disulfiram's influence on aldehyde dehydrogenase may affect acetyl-CoA levels, thus indirectly favoring E(z)'s methylation activity over acetylation on histone tails. RG108, by inhibiting DNA methylation, may create a need for increased histone methylation by E(z) as a compensatory mechanism for gene repression. Anacardic Acid disrupts the balance between acetylation and methylation, potentially enhancing the role of E(z) in adding repressive marks. Lastly, UNC1999, while a selective EZH1/EZH2 inhibitor, could paradoxically enhance E(z) activity through complex feedback loops within the cell that govern the homeostasis of epigenetic states. Collectively, these chemical activators, by influencing the intricate network of epigenetic regulation, ensure the amplification of E(z)'s role in maintaining gene silencing across the genome.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $184.00 $668.00 | 2 | |
Serves as a methyl donor in methyltransferase reactions, directly enhancing the histone methyltransferase activity of E(z). | ||||||
Methylstat | 1310877-95-2 | sc-507374 | 10 mg | $480.00 | ||
A competitive inhibitor of histone demethylases, indirectly augmenting E(z)-mediated methylation by preventing demethylation. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Causes depletion of trimethylated H3K27, a substrate of E(z), indirectly increasing the demand for E(z) activity. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
Inhibitor of G9a histone methyltransferase, may indirectly upregulate E(z) activity by shifting histone methylation patterns. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
NF-kB inhibitor that could indirectly increase E(z)'s activity by altering transcriptional networks that interface with E(z). | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Aldehyde dehydrogenase inhibitor that could increase acetyl-CoA levels, potentially influencing histone acetylation and E(z) role. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
DNA methyltransferase inhibitor, potentially enhancing E(z)'s compensation for changes in DNA methylation patterns. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Histone acetyltransferase inhibitor, may indirectly enhance E(z) histone methylation by shifting the balance of histone marks. | ||||||
Chaetocin | 28097-03-2 | sc-200893 | 200 µg | $126.00 | 5 | |
Inhibitor of histone methyltransferase SUV39H1, may lead to compensation by E(z)-mediated methylation. | ||||||